WebQuit Online Smoking Cessation Study

This study has been completed.
Sponsor:
Information provided by:
Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier:
NCT01166334
First received: July 19, 2010
Last updated: October 10, 2013
Last verified: October 2013
  Purpose

Would you like to quit smoking?

Seattle's Fred Hutchinson Cancer Research Center is launching a new study that may be able to help. Participants who enroll in this study will be randomly assigned by computer (like flipping a coin) to one of two online programs. The goal of this study is to learn which of these programs is the most effective at helping people stop smoking. Findings from this study will be used to help build more effective online smoking cessation programs in the future.

Participants in both of the smoking cessation programs used in this study will receive:

  • Interactive tools for dealing more effectively with urges to smoke
  • Step-by-step guides for quitting smoking
  • Personalized plans for quitting and remaining smoke-free
  • Electronic links for reaching one-on-one expert help for quitting

Participants will be asked to complete online questionnaires, including a brief three-month follow-up survey.

There is no cost for participating in this study.

To enroll in this study or for more information, please visit www.webquit.com.

This study is being conducted by Seattle's Fred Hutchinson Cancer Research Center (www.fhcrc.org), a world leader in advancing the prevention, diagnosis and treatment of cancer. The principal investigator for the WebQuit smoking cessation study is Dr. Jonathan Bricker, a faculty member at both the Hutchinson Center and at the University of Washington in Seattle.


Condition Intervention Phase
Smoking
Behavioral: WebQuit study group
Behavioral: WebQuit control group
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Treatment
Official Title: WebQuit Online Smoking Cessation Study

Resource links provided by NLM:


Further study details as provided by Fred Hutchinson Cancer Research Center:

Primary Outcome Measures:
  • 7-day point prevalence [ Time Frame: 3 months and 6 months post treatment ] [ Designated as safety issue: No ]
    No smoking in the past 7 days, as reported 3 months post treatment.


Enrollment: 721
Study Start Date: June 2010
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: WebQuit study group
Intervention arm 1 (identity and description withheld to protect integrity of study)
Behavioral: WebQuit study group
Description withheld to protect integrity of study
Active Comparator: WebQuit control group
Intervention arm 2 (identity and description withheld to protect integrity of study)
Behavioral: WebQuit control group
Identity and description withheld to protect integrity of study

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 18 or older
  • a current resident of the US
  • someone who has smoked daily for at least the past 12 months
  • someone who wants to quit smoking in the next 30 days
  • willing and able to read in English
  • able to connect to the Internet for at least one hour per week for three consecutive months
  • able to use a website
  • not participating in other smoking cessation interventions
  • willing and able to complete a Baseline Survey
  • willing to be randomized to either online program

Exclusion Criteria:

  • inability to meet inclusion criteria
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01166334

Locations
United States, Washington
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States, 98109
Sponsors and Collaborators
Fred Hutchinson Cancer Research Center
Investigators
Principal Investigator: Jonathan Bricker, PhD Fred Hutchinson Cancer Research Center
  More Information

No publications provided

Responsible Party: Jonathan Bricker, PhD, Fred Hutchinson Cancer Research Center
ClinicalTrials.gov Identifier: NCT01166334     History of Changes
Other Study ID Numbers: FHCRC IR#7181
Study First Received: July 19, 2010
Last Updated: October 10, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Fred Hutchinson Cancer Research Center:
Smoking
Smoke
Cigarette
Cessation
Quit
Online
Web
Stop

Additional relevant MeSH terms:
Smoking
Habits

ClinicalTrials.gov processed this record on July 26, 2014